Gilbert & Cook’s Insmed INSM Stock Holding History

Gilbert & Cook’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,841	Closed	-$465K	–	234
2026 Q1	$465K	Sell	2,841 -8	-0.3%	-$1.23K	0.06%	154
2025 Q4	$496K	Buy	+2,849	New	+$520K	0.06%	157

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Gilbert & Cook's INSM Position: Q2 2026 in Review

Gilbert & Cook sold out of Insmed (INSM) in Q2 2026, closing a stake of 2,841 shares — an estimated $465K sold.

Gilbert & Cook first reported a position in INSM in Q4 2025 and held it in 2 quarters. The position peaked at $496K in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Gilbert & Cook reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
Gilbert & Cook sold 2,841 Insmed shares in Q2 2026, an estimated $465K.
Gilbert & Cook first reported a position in Insmed in Q4 2025 and held it in 2 quarters.
Gilbert & Cook's Insmed position peaked at $496K in Q4 2025.
666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Gilbert & Cook's 13F filing for Q2 2026, filed 28 Jul 2026.